News Summary

Researchers from the University of Colorado Boulder, CU Anschutz, and Colorado State University have developed promising new therapies for osteoarthritis, which affects millions globally. With a $33.5 million grant from the Advanced Research Projects Agency for Health (ARPA-H), the team has created a regenerative injection and biomaterial repair kit. These treatments aim to recruit the body’s own cells to repair damaged joints, potentially reversing osteoarthritis in a matter of weeks. Initial animal studies have shown encouraging results, with treated joints returning to a healthy state within four to eight weeks. Renovare Therapeutics, the startup founded by the researchers, plans to commercialize the therapy, with human clinical trials anticipated within 18 months.